Columbia Stock Soars (CBRX)

NEW YORK ( TheStreet) -- Shares of Columbia Laboratories (Nasdaq: CBRX) have taken a tremendous swing upward. The stock is trading at 85 cents as of 12 p.m. ET, 20.3% above Monday's closing price of 71 cents. Volume is at 4.9 million, 4.4 times the daily average of 1.1 million.

Columbia has a market cap of $137.9 million and is part of the health care sector and drugs industry. Shares are down 71.8% year to date as of the close of trading on Monday.

Columbia Laboratories, Inc. engages in the research, development, and commercialization of women's healthcare and endocrinology products. It develops products by utilizing its bioadhesive drug delivery technologies. The company has a P/E ratio of 11.3, below the average drugs industry P/E ratio of 19.8 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Columbia as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full Columbia Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.
null